Tumor Cell Killing | List of Frontiers open access articles

Original Research

Published on 27 Oct 2022

Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing

in Cancer Immunity and Immunotherapy

Seong-Eun Kim
Suji Yun
Junsang Doh

Frontiers in Immunology

doi 10.3389/fimmu.2022.1004171

4,925 views
8 citations

Original Research

Published on 16 Aug 2021

Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models

in Cancer Immunity and Immunotherapy

Karsten M. Warwas
Marten Meyer
Márcia Gonçalves
Gerhard Moldenhauer
Nadja Bulbuc
Susanne Knabe
Claudia Luckner-Minden
Claudia Ziegelmeier
Claus Peter Heussel
Inka Zörnig

Frontiers in Immunology

doi 10.3389/fimmu.2021.719116

26,815 views
34 citations

Correction

Published on 09 Jan 2023

Corrigendum: Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing

in Cancer Immunity and Immunotherapy

Seong-Eun Kim
Suji Yun
Junsang Doh

Frontiers in Immunology

doi 10.3389/fimmu.2022.1132806

1,320 views

Methods

Published on 30 Apr 2019

Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing

in NK and Innate Lymphoid Cell Biology

Tiziano Ingegnere
Francesca Romana Mariotti
Andrea Pelosi
Concetta Quintarelli
Biagio De Angelis
Nicola Tumino
Francesca Besi
Claudia Cantoni
Franco Locatelli
Paola Vacca

Frontiers in Immunology

doi 10.3389/fimmu.2019.00957

43,228 views
120 citations

Mini Review

Published on 10 May 2021

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies

in Radiation Oncology

Jacob Ukleja
Erika Kusaka
David T. Miyamoto

Frontiers in Oncology

doi 10.3389/fonc.2021.663852

10,099 views
30 citations

Review

Published on 30 Jun 2016

Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy

in Radiation Oncology

Ying-Chieh Yang
Chi-Shiun Chiang

Frontiers in Oncology

doi 10.3389/fonc.2016.00165

6,982 views
12 citations

Review

Published on 12 Jun 2025

Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies

in Cancer Immunity and Immunotherapy

Ting-Ting Chen
Xiong Li
Yi Zhang
Xiao-Juan Kang
Shu-Fang Zhang
Tong Zhang
Deji Sangmao
Ya-Juan Zhu
De-Kui Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1614228

4,041 views
6 citations

Original Research

Published on 29 Sep 2022

IFN-γ enhances the antitumor activity of attenuated salmonella-mediated cancer immunotherapy by increasing M1 macrophage and CD4 and CD8 T cell counts and decreasing neutrophil counts

in Biomaterials

Huimin Xu
Linghua Piao
Yundi Wu
Xiande Liu

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.996055

4,250 views
19 citations

Original Research

Published on 13 Aug 2024

Mn-ZIF nanozymes kill tumors by generating hydroxyl radical as well as reversing the tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Jiyu Han
Hairong Ma
Songtao Ai
Daqian Wan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441818

2,085 views
3 citations

Original Research

Published on 27 Oct 2025

Senescent human fibroblasts have increased FasL expression and impair the tumor immune response

in Cancer Immunity and Immunotherapy

Monica Cruz-Barrera
Joshua Dulong
Georgio Mansour Nehmo
Anthony Sonn
Gaël Moquin-Beaudry
Basma Benabdallah
Oanh Le
Christian Beauséjour

Frontiers in Immunology

doi 10.3389/fimmu.2025.1685269

1,724 views
2 citations

Original Research

Published on 28 Sep 2018

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

in Molecular and Cellular Oncology

Deepika Nair
Emelie Rådestad
Prajakta Khalkar
Nuria Diaz-Argelich
Axel Schröder
Charlotte Klynning
Johanna Ungerstedt
Michael Uhlin
Aristi P. Fernandes

Frontiers in Oncology

doi 10.3389/fonc.2018.00407

6,183 views
20 citations

Original Research

Published on 30 Jan 2026

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing

in Cancer Immunity and Immunotherapy

Fabio Morandi
Martina Della Lastra
Fabio Pastorino
Eleonora Ciampi
Maura Faraci
Chiara Brignole
Stefano Giardino
Irma Airoldi

Frontiers in Immunology

doi 10.3389/fimmu.2026.1755500

1,052 views

Perspective

Published on 15 Apr 2020

Perspective: Designing T-Cell Engagers With Better Therapeutic Windows

in Cancer Immunity and Immunotherapy

Omid Vafa
Nathan D. Trinklein

Frontiers in Oncology

doi 10.3389/fonc.2020.00446

43,608 views
76 citations

Original Research

Published on 16 Feb 2024

Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing

in Cancer Immunity and Immunotherapy

Michel Demeule
Jean-Christophe Currie
Cyndia Charfi
Alain Zgheib
Isabelle Cousineau
Véronique Lullier
Richard Béliveau
Christian Marsolais
Borhane Annabi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355945

7,385 views
10 citations

Original Research

Published on 22 Jul 2022

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition

in Cancer Immunity and Immunotherapy

Luise Victoria Claaß
Christoph Schultheiß
Rebekka Scholz
Lisa Paschold
Donjete Simnica
Volker Heinemann
Sebastian Stintzing
Mascha Binder

Frontiers in Oncology

doi 10.3389/fonc.2022.941666

4,442 views
1 citation

Review

Published on 03 Mar 2025

The role of type I interferon signaling in myeloid anti-tumor immunity

in Inflammation

Sofie Patrizia Meyer
Rebekka Bauer
Bernhard Brüne
Tobias Schmid

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547466

5,831 views
8 citations

Articles

Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing

Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models

Corrigendum: Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing

Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies

Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy

Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies

IFN-γ enhances the antitumor activity of attenuated salmonella-mediated cancer immunotherapy by increasing M1 macrophage and CD4 and CD8 T cell counts and decreasing neutrophil counts

Mn-ZIF nanozymes kill tumors by generating hydroxyl radical as well as reversing the tumor microenvironment

Senescent human fibroblasts have increased FasL expression and impair the tumor immune response

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing

Perspective: Designing T-Cell Engagers With Better Therapeutic Windows

Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition

The role of type I interferon signaling in myeloid anti-tumor immunity